But the New York-listed owner still travels the bumpy road to a full recovery, as was borne out by the dramatic nosedive of its stock on 10 February — to $5.50 from a previous close of $6.46 (down 15%).
There was no negative news affecting the dry bulk market. Indeed, most of Eagle’s peers traded up on the day. And there were no troubling developments flowing specifically from Eagle.
